Printable Version

Back to Previous Page


  • Hikima, T.; Komatsu, M.; Mori, D.; Tojo, K.
    Prediction of Percutaneous Absorption in Human of Nicotine from Marketed TTS using Three-dimensional Human Cultured Epidermis
    40th Annual Meeting & Exposition of the Controlled Release Society, Honolulu, Hawaii, July 21-24, 2013.

  • Hikima, T.; Kaneda, N.; Matsuo, K.; Tojo, K.
    Prediction of percutaneous absorption in human using three-dimensional human cultured epidermis LabCyte EPI-MODEL
    Biol. Pharm. Bull. 35(3): 362-368, 2012.

  • Nakamura, A. ; Mori, D. ; Tojo, K.
    Evaluation of the predicted time-concentration profile of serum tulobuterol in human after transdermal application
    Chem. Pharm. Bull. 60(3): 300-305, 2012.

  • Olatunji, O.; Das, D.B.; Nassehi, V.
    Modelling transdermal drug delivery using microneedles: Effect of geometry on drug transport behaviour
    J. Pharm. Sci. 101(1): 164-175, 2012.

  • Tominaga, K.; Tojo, K.
    Effect of environmental temperature on transdermal drug penetration
    Biol. Pharm. Bull. 33(12): 1983-1987, 2010.

  • Olatunji, O.; Das, D.B.; Al-Qallaf, B.
    Simulation based optimization of microneedle geometry to improve drug permeability in skin
    7th Annual Industrial Simulation Conference (ISC’2009), Loughborough, UK, June 1-3, 2009.

  • Kimura, C.; Tojo, K.
    Stick-type transdermal delivery system for ocular diseases
    2007 AAPS Annual Meeting and Exposition, San Diego, CA, November 10-15, 2007.

  • Al-Qallaf, Barrak; Mori, Daisuke; Olatunji, Lola; Das, Diganta Bhusan; and Cui, Zhanfeng
    Transdermal Drug Delivery by Microneedles: Does Skin Metabolism Matter?
    International Journal of Chemical Reactor Engineering: Vol. 7: A69, 2009.

  • Barrak Al-Qallaf and Diganta Bhusan Das
    Optimization of square microneedle arrays for increasing drug permeability in skin
    Chem. Eng. Sci., 63: 2523-2535, 2008.

  • Barrak Al-Qallaf, Diganta Bhusan Das, Daisuke Mori and Zhanfeng Cui
    Modelling transdermal delivery of high molecular weight drugs from microneedle systems
    Phil. Trans. R. Soc. A, 365(1861), 2951–2967, 2007.

  • Kakuji Tojo and Tomohiro Hikima
    Bioequivalence of Marketed Transdermal Delivery Systems for Tulobuterol
    Biol. Pharm. Bull., 30(8): 1576-1579, 2007.

  • Chiharu Kimura and Kakuji Tojo
    Development of a stick-type transdermal eyelid delivery system of ketotifen fumarate for ophthalmic diseases
    Chem. Pharm. Bull., 55(7): 1002-1005, 2007.

  • Daisuke Mori and Kakuji Tojo
    SKIN-CAD®: Pharmacokinetic Model for Transdermal Drug Delivery
    AIChE Annual Meeting 2006, San Francisco (USA), November 14, 2006.

  • A. Isowaki, A. Ohtori , Y. Matsuo, and K. Tojo
    Drug Delivery to the Eye with a Transdermal Therapeutic System
    Biol. Pharm. Bull., 26(1): 69-72, 2003.

  • Daisuke Mori, Hideki Kawamata, and Kakuji Tojo
    Drug Concentration - Time Profile in the Plasma Following the Dissolution-Type Transdermal Delivery
    J. Chem. Eng. Japan, 36(1): 45-48, 2003.

  • Hideki Kawamata and Kakuji Tojo
    Prediction of Plasma Concentration of GTS-21 in Hairless Rats Following Monolithic Transdermal Delivery
    Biol. Pharm. Bull., 25(3): 342-345, 2002.

  • D. Mori and K. Tojo
    In Silico Evaluation for Skin Pharmacokinetics
    29th Annual Meeting of Controlled Release Society, Seoul (Korea), July 21, 2002.